{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/335240839"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "We also collaborate on the development and commercialization of RITUXAN and anti-CD20 product candidates for the treatment of non-Hodgkin's lymphoma and other conditions." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sec.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/277461915"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/335240839"] } } }
